Proxymetacaine 0.5% Eye Drops (Minims Proxymetacaine)
Brand names: Minims Proxymetacaine
Proxymetacaine eye drops (Minims proxymetacaine) are a single-use topical ophthalmic local anaesthetic used to provide brief corneal and conjunctival anaesthesia for diagnostic and minor procedures.
Adult dose
Paediatric dose
Dose independently re-sourced from UK Summary of Product Characteristics (SPC) via the eMC — clinician-reviewed. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Known hypersensitivity to any component of the preparation — 'Do not use in patients with a known hypersensitivity to any component of the preparation'
- Premature babies — 'In view of the immaturity of the enzyme system which metabolises the ester type local anaesthetics in premature babies, this product should be avoided in these patients'
- Not a contraindication but an explicit caution (§4.4): use cautiously and sparingly in patients with known allergies, cardiac disease or hyperthyroidism, because of the increased risk of sensitivity reactions
- Do not use if the solution is more than pale yellow in colour
Side effects
- Pupillary dilatation or cycloplegic effects — rarely observed with proxymetacaine hydrochloride preparations
- Irritation of the conjunctiva, or other toxic reactions — have occurred only rarely
- A severe, immediate-type apparently hyperallergic corneal reaction may rarely occur: acute, intense and diffuse epithelial keratitis; a grey ground-glass appearance; sloughing of large areas of necrotic epithelium; corneal filaments; and sometimes iritis with descemetitis
- With regular and prolonged use (not intended for long term use): softening and erosion of the corneal epithelium, which could produce corneal opacification with accompanying loss of vision
Monitoring
- Protect the eye from rubbing, irritating chemicals and foreign bodies throughout the period of anaesthesia — advise the patient to avoid touching the eye until the anaesthesia has worn off
- Watch for signs of local irritation or hypersensitivity; discontinue if a severe corneal reaction develops
- Where repeated or prolonged instillation has occurred, examine the cornea for epithelial softening, erosion or opacification
- Compress the lacrimal sac at the medial canthus for a minute during and after instillation to limit systemic absorption, especially in children and in an inflamed (hyperaemic) eye
Clinical monograph
How it works
Proxymetacaine is an ester local anaesthetic that reversibly blocks sodium channels in ocular surface sensory nerves, abolishing pain transmission for a short period.
Prescribing in practice
- Topical ocular anaesthetics must never be supplied for repeated or take-home use, as repeated application causes corneal toxicity and can result in severe, sight-threatening keratopathy.
- Single-use Minims units should be discarded after one application to maintain sterility.
- The blink reflex is temporarily lost, so the eye must be protected until sensation returns.
Monitoring
Monitoring is clinical; confirm return of corneal sensation and surface integrity after the procedure.
Counselling the patient
- The eye will feel numb briefly; avoid rubbing or touching it until feeling returns.
- Protect the eye from injury while it is numb.
- These drops are for use by clinicians during procedures only, not for treating pain at home.
Evidence & guidelines
Single-use anaesthetic Minims are widely used for ophthalmic assessment, with SPC and MHRA advice cautioning against unsupervised repeated use.
Reference: RCOphth Ophthalmic Trauma Guidelines; Minims Proxymetacaine SPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Intraocular Pressure Stratification & Glaucoma Risk · Glaucoma
- Roper-Hall Classification of Chemical Ocular Burns · Ocular Trauma
- Dua Classification of Chemical Ocular Injuries · Ocular Trauma
- Traumatic Hyphaema Grading · Ocular Trauma
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme